Fabry Disease Market Enzyme Replacement Therapy Trials Showing Renal Stabilization 2026
Advancements in Intravenous Infusion Protocols
Enzyme Replacement Therapy (ERT) remains a cornerstone in the management of individuals with this complex lysosomal storage disorder, caused by a deficiency in the alpha-galactosidase A enzyme. The therapy works by intravenously infusing a functional version of the deficient enzyme,...
0 Поделились
63 Просмотры